Erica Jordan, Chief Commercial Officer: Revance Therapeutics RVNC Sell · Filed 24/04/17

Trade details

Type: Insider sale
Amount: $9,089.6
Shares · price: 2,392 sh · $3.80 a share
Held after: 114,864 sh
Stock: Revance Therapeutics RVNC
Person: Erica JordanChief Commercial Officer
Trade date: 24/04/16
Filed: 24/04/17
Days to filing: 1 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/17~24/05/16

Erica Jordan's recent trades

No other trades yet.